Shibani Naik

Shibani Naik, Ph.D., is a seasoned professional in biopharmaceutical product development with extensive experience in project management and technical expertise across multiple companies. Currently serving as a Manager at Bavarian Nordic, Shibani Naik specializes in biologics for Phase 3 and commercial readiness, overseeing multiple vaccine development projects. Previous roles include Scientist/Manager at Emergent BioSolutions, focusing on Phase 3 clinical trials and product management, and Sr. Scientist at Arisan Therapeutics, where leadership in antiviral candidate development was emphasized. With a robust educational background in Immunobiology from Iowa State University and Biotechnology from Jaypee University of Information Technology, Shibani Naik has contributed to various research initiatives, including the development of diagnostic assays and molecular diagnostics for infectious diseases.